Absence of 185delAG mutation of the BRCA I gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer
1998

BRCA Gene Mutations and Prostate Cancer in Ashkenazi Men

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): S Lehrer, F Fodor, RG Stock, NN Stone, C Eng, HK Song, M McGovern

Primary Institution: Mount Sinai School of Medicine

Hypothesis

Do BRCA1 and BRCA2 mutations contribute to prostate cancer in Ashkenazi Jewish men?

Conclusion

The study found no BRCA1 or BRCA2 mutations in the 60 Ashkenazi men with prostate cancer, suggesting their contribution to prostate cancer incidence is likely small.

Supporting Evidence

  • None of the 60 men studied carried the 185delAG or 6174delT mutations.
  • A previous study found 16 out of 268 Ashkenazi Jewish women with breast cancer carried the mutations.
  • The study suggests that the contribution of BRCA mutations to prostate cancer is likely limited to specific subgroups.

Takeaway

The researchers looked for specific gene mutations in men with prostate cancer but didn't find them, which means those mutations probably don't cause prostate cancer in these men.

Methodology

The study involved testing for BRCA1 and BRCA2 mutations in 60 Ashkenazi men with prostate cancer using DNA from blood samples.

Limitations

The study's findings may not apply to all populations, as it focused only on Ashkenazi Jewish men.

Participant Demographics

Participants were Ashkenazi Jewish men aged 55 to 80 years.

Statistical Information

P-Value

0.05

Statistical Significance

p=0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication